Jennifer Good | President and CEO |
Chris Seiter | Chief Financial Officer |
Bill Forbes | Chief Development Officer |
Gary Nachman | BMO Capital Markets |
Annabel Samimy | Stifel |
Serge Belanger | Needham & Company |
Good afternoon, and welcome to the Trevi Therapeutics Year End 2020 Earnings Conference Call [Operator Instructions].
As a reminder, this call may be recorded. Various remarks that management makes during this call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risks Factors section of the company's most recent annual report on Form 10-K, which the company filed this afternoon.
In addition, any forward-looking statements represent the company's views only as of today and should not be relied upon as representing views as of any subsequent date.